ObjectivePatients with breast cancer carrying BRCA1 and BRCA2 genetic alterations show poor prognoses. However. the efficacy of pharmacotherapies for patients with advanced breast cancer carrying BRCA1/2 pathogenic variants remains unclear. This study aimed to conduct a network meta-analysis to assess the efficacy and safety of various pharmacotherapies for patients with metastatic. https://www.roneverhart.com/HP-ENVY-TE01-4147c-Desktop-Intel-Core-i7-13700-2-1-GHz-Intel-UHD-Graphics-770-32GB-DDR4-512GB-SSD-1TB-HDD-Windows-11-/